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CHAPTER I
INTRODUCTION
Purpose

The illegal abuse of cocaine has become a major concern, particularly since the
advent in the middle 1980's of "crack," a relatively pure and cheap alkaloidal form of the
drug (Phibbs et al., 1991; Van Dyke and Fox, 1990). The continued widespread use of
cocaine created an increased use among women of reproductive age (Chavez et al., 1989).
It has been reported that in inner city hospitals as many as one out of four women who have

given birth have used cocaine during pregnancy (Fackelman, 1991). Consequently, since
cocaine can cross the placental blood barrier (Chasnoff, 1990), the effects of exposure of
developing fetuses to cocaine have become of direct concern. Infants who have been
exposed to cocaine during pregnancy have shown a high degree of irritability and
tremulousness during postnatal week one (Chasnoff, 1990).

Long-term effects from

exposure to cocaine have been difficult to follow, primarily due to costs and socio-economic
factors that may confound data. For example, the quality of pre- and post-natal care,
nutrition, and social environment, including family and schooling, may all cloud
observations of the effects of cocaine itself. Other confounding variables may include
maternal age during pregnancy, variations in the method of cocaine administration,
frequency of use, and multiple drug abuse. Because I can control a majority of these factors
in animal studies, I may be better able to understand the effects cocaine has on the human
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fetus by investigating them in an animal model in the laboratory.
Laboratory studies have shown that prenatal exposure to cocaine in rats has results
in increased mortality and teratological abnormalities in rat pups (Church et al., 1990b).
This has particularly been the case with higher doses of cocaine exposure, around 801OOmg/kg body weight (Church et al., 1990a, b ). Studies concentrating on more subtle
characteristics such as behavior, rather than on gross morphologic abnormalities, have shown
that prenatal exposure to cocaine delays appearance of certain neurological indices such as
righting reflex and cliff avoidance (Henderson and MacMillan, 1990, Van Dyke and Fox,
1990). Appearance of these reflex behaviors indicates maturation of the central nervous
system; their delay, therefore, suggests effects of cocaine on neurological ontogeny.
The neurotransmitters that cocaine affects are also some of the ones that regulate
gonadotropin secretion in adulthood (Gallo and Drouva, 1979; Cabrera et al., 1993). Lauder
has suggested that, in general, neurotransmitters (NTs) direct embryological development
of the same systems that they will control in adulthood (Lauder and Krebs, 1986). It seems
reasonable, therefore, that perinatal exposure to cocaine might alter gonadotropin regulation
in adult rats. Gonadotropin regulation has been shown to be a sexually differentiated
characteristic. For example, males exhibit tonic levels of the gonadotropin luteinizing
hormone (LH), while females exhibit a cyclic pattern of LH secretion. Studies conducted
by Dow-Edwards have shown that glucose utilization in the brain is a sexually differentiated
characteristic in rats, and that its sexually differentiated nature is affected by cocaine (DowEdwards, 1988). The purpose of my experiments was to test the hypothesis that perinatal
exposure to cocaine during the critical period of sexual differentiation of the brain will alter
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normal sexually differentiated gonadotropin regulation. Specifically, I hypothesize that
perinatal treatment with cocaine will induce LH-surges in males, but that in females they will
either decrease in magnitude or remain the same. I also will measure various aspects of
maternal metabolism, including maternal weight gain and nutritional intake, in addition to
effects of perinatal exposure to cocaine on birth weight of pups, litter size, and offspring
weight gain.

Literature Review

Effects of cocaine on neurotransmitters:
Nerve impulses travel down neurons in the form of action potentials. Once the
electrical signal reaches the terminus, neurotransmitters (NTs) stored within vesicles located
at the terminal end of the neuron are released. Once the NTs are released into the synaptic
cleft, they can bind to specific receptors located on the postsynaptic neuron which will carry
on the signal. NTs within the cleft can also be destroyed by certain enzymes or recycled by
the presynaptic neurons via reuptake receptors. Cocaine acts at the level of the presynaptic
neuron by blocking reuptake receptors (Dackis and Gold, 1985; Vathy et al., 1993). The
inability of presynaptic neurons to take up NTs results in an increased concentration of NTs
within the synaptic cleft, causing hyperstimulation of postsynaptic neurons (Diagram 1).
This hyperstimulation is associated with the euphoria that is experienced shortly after taking
cocaine (Dackis and Gold, 1985). The NT primarily responsible for this experience of
euphoria is dopamine (DA), a catecholamine NT that is influenced profoundly by cocaine

f
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Diagram 1. Effects of cocaine on neurotransmitters. Cocaine blocks reuptake receptors at the level of presynaptic
neu.rons. The increased concentrations of NTs within the synaptic cleft cause hyperstimulation of postsynaptic
neurons.
~

5
and plays an important role in reward states. The euphoric state due to hyperstimulation is
only transitory and is soon replaced by a state of dysphoria also known as "crashing."
"Crashing" from cocaine is thought to be due to depletion ofNTs, particularly dopamine.
The increased concentration ofNTs in the synaptic cleft increases the chance of diffusion
into surrounding blood vessels.

This depletion may be partially offset by increased

production of NTs by presynaptic neurons due to homeostatic regulation, but it is
hypothesized that during chronic cocaine abuse the increased production cannot completely
compensate for the more rapid depletion, which results in a progressive dysphoric state
(Dackis and Gold, 1985).
Recently, researchers have found evidence that supports the idea of homeostatic
regulation of DA levels, and the key role DA transporters play in that regulation. Giros et
al. created a strain of "knock out" mice which lack the gene for the dopamine transporter
(reuptake receptor) (Giros et al., 1996). The mice, lacking the dopamine transporter gene,
were hyperactive as expected. These mice also had lower levels of DA compared to normal
strains of mice. Low levels of DA in the "knock out" mice were consistent with lower levels
of tyrosine hydroxylase, the rate-limiting enzyme in DA synthesis. Down-regulation of DA
release from the presynaptic neurons appears to serve as a mechanism to compensate for the
inability of these mice to take up DA. It is also interesting that the "knock out" mice were
hyperactive even in the face of low levels of DA. This suggests that the extent of depletion
of NTs responsible for the dysphoric state is almost complete. Furthermore, intraperitonial
injection of 40mg/kgbwt cocaine had no significant effect on locomotor activity in these
mice. Normal mice, however, produced a 6- to 8-fold increase in locomotor activity upon
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the same stimulant, providing strong evidence for the role DA and its reuptake receptor play
in the action of cocaine (Giros et al., 1996).
The study of Giros et al. (1996) concentrated on DA's role in the addictive action of
cocaine. It should be noted that the DA transporter is member of a family of Na/Cl
dependent transporters whose members also include transporters specific for norepinephrine
(NE) and serotonin (5-HT), the two other NTs most strongly affected by cocaine. Although
members of this family of transporters do display substrate specificity, there is some overlap,
which would explain cocaine's ability to bind to all three transporters.
The purpose of my experiment was to determin the effect of perinatal exposure to
cocaine on sexual differentiation of the brain in rats. NE, 5-HT and DA are important in
sexually differentiated functions of the brain in adults and are also thought to be important
during development of those functions. It has been postulated that NTs may act as a signal
for synaptogenesis in target neurons during development of the brain (Lauder, 1983; DowEdwards, 1988; Raum et al., 1990). Development of sexually differentiated characteristics
in the brains of rats occurs between a few days before birth (prenatally) and a few days after
birth (postnatally). This period is called the critical period of sexual differentiation of the
brain. Therefore, exposure to cocaine around the time of birth (perinatally) may irreversibly
alter normal sexually differentiated functions in adults.

Sexual differentiation of the rat brain:
Sexual differentiation of the rat brain seems to be under steroidal influence similar
to that responsible for sexual differentiation of the genital tract. Development of the female
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or male brain appears to depend on testosterone, which acts like a switch. In the presence
of testosterone the brain develops along a male pattern, and in the absence of testosterone the
brain develops along a female pattern. Treating female rat pups with testosterone during the
critical period for sexual differentiation of the brain causes them to exhibit male behaviors
as adults. Orchidectomy of male rat pups during the critical period results in male adult rats
exhibiting female behaviors (reviewed by Dohler, 1991 ). Although testosterone is the
androgenizing hormone for the internal genitalia, estradiol is the hormone directly
responsible for masculinization of the brain. Testosterone taken up by the brain is converted
to estradiol by aromatase (Gorski, 1985). Recent studies conducted by McCarthy et al. have
shown the masculinizing effect of estrogen using a new method. By infusing an antisense
oligonucleotide for estrogen receptor mRNA into the ventromedial hypothalamus in 3-dayold female rats in combination with an injection of testosterone, McCarthy et al. were
successfully able to attenuate the androgenizing effects of testosterone (McCarthy et al.,
1993).
If estrogen is the masculinizing hormone, it would seem likely that females would

be exposed to these masculinizing effects since during this period circulating estrogens are
present. In fact, substantial amounts of placental estrogens are present at this time in fetuses
of both sexes. The placental estrogens, however, are tightly bound to alpha-fetoproteins and
are thus unable to diffuse into the brain and cause masculinization in either sex (Gorski,
1985).
Researchers have shown that prenatal exposure to cocaine can reduce hypothalamic
uptake of estradiol (Raum et al., 1990). Therefore, reduced availability of estradiol may
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prevent development of male-like patterns. In fact, Raum and his colleagues have shown
that perinatal exposure to cocaine can reduce the scent-marking behavior typical of males
(Raum et al., 1990). Therefore, I hypothesized that perinatal exposure to cocaine would
prevent development of male-typical LH regulation and induce the capacity to have steroidinduced LH surges, typical of females.

Sexually differentiated structures of the brain:
Sexual differentiation of the brain can be categorized into the development of
structural, behavioral, or physiological differences. A key structural difference between male
and female rats was found by Gorski et al. in 1978. Within the preoptic area (POA) of the
rat brain there is a nucleus, or collection of cell bodies, that is significantly larger in males
than in females. This region was termed the sexually dimorphic nucleus of the preoptic area
(SDN-POA) (Gorski et al., 1978; Gorski, 1985). From further studies on the SDN, Gorski

et al. were able to demonstrate that female pups perinatally exposed to testosterone
developed SDNs of increased size. Therefore, it appears that the SDN-POA volume is
determined by the hormonal environment during the critical period for sexual differentiation
of the brain (Gorski, 1985).
The structural differences found between the SDN s of males and females may be
responsible for some behavioral differences exhibited between the sexes. Studies conducted
by Houtsmuller et al. ( 1994) have shown that perinatal treatment with the aromatase inhibitor
1,4,6-androstatriene-3,17-dione significantly reduced the size of the SDN-POA in males and
reduced the frequency of male sexual behaviors in adult offspring. Furthermore, the size of
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the SDN-POA and the frequency of male sexual behavior were shown to be positively and
significantly correlated. By inhibiting aromatase, the researchers appear to have been
successful in preventing the conversion of testosterone to estradiol, thus preventing the
masculinizing effects of testosterone (Houtsmuller et al., 1994) on both the SDN-POA and
the behavioral consequences of its development.
Another structure of the brain that has been found to be sexually differentiated in rats
is the anteroventral periventricular nucleus (AVPV) of the preoptic region. This nucleus,
unlike the SDN-POA, is larger in females than in males. One of the functional roles of the
AVPV appears to be participation in the regulation of gonadotropin-releasing hormone
(GnRH) secretion. By introducing electrolytic lesions of the AVPV, researchers were able
to induce persistent estrus in female rats and to eliminate the preovulatory surge of LH.
Perinatal manipulation of steroids altered AVPV volume in the opposite way from SDNPOA volume (Gu and Simerly, 1994).
The exact mechanism by which steroids influence SDN-POA and AVPV volumes
is still unknown. Steroids may increase neurogenesis, stimulate migration of neurons, or
prevent death of existing neurons (Gorski, 1985). As stated earlier, the structural differences
found between the SDN-POA and AVPV of males and females may be responsible for some
physiological and behavioral differences exhibited by the sexes. Other areas of the brain,
however, are also involved in sexual differentiation, and the information now known about
the SDN-POA and AVPV may best serve as a model for understanding sexual differentiation
of the brain in general.
As discussed above, sexual differentiation of the brain appears to be highly regulated
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by the hormonal environment during the critical period. The mechanism by which steroids
mediate these and many other actions involves intracellular steroid receptors. Therefore, sex
differences seen in adults may be related to estrogen receptor (ER) concentrations during
development. In fact, sexual differences in ER levels have been found in the medial preoptic
area (MPOA) and the periventricular region of the preoptic area (PVP), where ER levels
were higher in females than in males. These sex differences in ER levels have been detected
as early as 24 hours after birth (Kuhnemann et al., 1994). These data are further supported
by sex differences found in ER mRNA levels in neonatal rats, with higher levels of ER
mRNA found in females than males (DonCarlos et al., 1995). Like the SDN-POA and
AVPV, perinatal manipulation of hormones can also alter normal sexually differentiated ER
mRNA levels. Perinatal treatment of female rats with estrogen reduced ER mRNA levels
to levels comparable to males. Also, neonatal orchidectomy of male rats increased the level
of ER mRNA to a level comparable to normal females (DonCarlos et al., 1995).
The sexually differentiated structures of the brain which have just been discussed all
appear to be influenced by the steroidal environment during the critical period for sexual
differentiation of the brain. Raum et al. (1990) have shown that prenatal exposure to cocaine
can alter the steroidal environment during the critical period. Therefore, perinatal exposure
to cocaine may alter sexually differentiated structures involved in gonadotropin regulation.

Sexually differentiated behaviors:
The differences between male and female rats in the structures of certain regions of
the brain (SDN-POA and AVPV) and in levels of ER may be responsible for behavioral
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differences observed between males and females. For example, a female-typical mating
behavior in rats is the lordosis reflex. The tactile stimulation of males' attempting to mount
can induce females to arch their backs in a posture that permits intromission. Lordosis can
be induced with steroids in adult females, but adult males do not exhibit this behavioral
response when treated with the same steroids. Male-typical sexual behaviors in rats include
mounting and intromission. Adult males treated with testosterone display these behaviors
when placed with a receptive female. Normal adult females treated with testosterone cannot
be induced to display the male-typical sexual behaviors.
Altering the steroidal environment during the critical period for sexual differentiation
of the brain can, however, alter normal female and male behaviors. Transplantation of testes
into females or treatment of females with testosterone or estrogen during the early postnatal
period can disrupt the lordosis reflex in those rats when they are adults. These adult females
also show the capacity to display mounting and intromission behaviors upon treatment with
testosterone. Early postnatal treatment of males with an estrogen antagonist can interfere
with adult male behaviors, and enable adult males to display the female lordosis reflex when
treated with estrogen and progesterone (Dohler, 1991).
Hanousek et al. (1994, 1996) have shown that perinatal exposure to cocaine delayed
development of sex differences in play behavior in juvenile rat pups without affecting most
non-sexually differentiated aspects of open-field activity. Furthermore, Raum et al. (1990)
demonstrated a decrease in mounting behavior in adult males perinatally exposed to cocaine.
These results suggest that exposure to cocaine during the critical period for sexual
differentiation of the brain may have an important impact on sexually differentiated function
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in adult life.

Sexually differentiated physiology:
A highly sexually differentiated physiological function is the regulation of
gonadotropins. The gonadotropins consist of luteinizing hormone (LH), follicle-stimulating
hormone (FSH), and prolactin (PRL). Gonadotropin regulation is a sex-dependent process
that is programmed during the critical period for sexual differentiation for the brain. My
research focused on the gonadotropin LH, a glycoprotein secreted by the anterior pituitary.
In females, LH triggers ovulation and stimulates secretion of steroids by the ovaries, and in
males, LH stimulates the testes to secrete testosterone.
In adult males LH release by the pituitary gland is tonic, whereas in females LH
release is cyclic in nature (Gorski and Wagner, 1965; Dohler, 1991). Transplantation
experiments have shown that pituitaries surgically removed from donors of one sex and
implanted in recipients of the opposite sex perform in a normal manner with respect to the
recipient (Gorski, 1985). Therefore, it appears that the difference in LH regulation between
males and females is not due to the pituitary gland but rather to regions of the hypothalamus
that regulate gonadotropin-releasing hormone (GnRH) or to regions innervating the
hypothalamus.
LH release in males is regulated by a negative feedback loop involving the level of
circulating steroids. Low steroid levels stimulate the hypothalamus to secrete GnRH which
stimulates the pituitary gland to secrete LH. Increased levels of LH in circulation stimulate
the gonads to secrete steroids. High steroid levels inhibit the hypothalamus, attenuating
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release of GnRH. Attenuated GnRH secretion reduces release of LH by the pituitary which
ultimately reduces steroid secretion by the gonads.

This negative feedback loop is

responsible for the relatively constant levels ofLH characteristic of males (Gorski, 1985).
In females, LH release is under the influences of a negative feedback system similar
to that of males, along with a positive feedback system unique to females. During the estrous
cycle of the female rat, 4-5 days in length, levels of estrogen become increasingly high and
peak on the day of proestrus. High levels of estrogen positively feedback at the level of the
hypothalamus and the anterior pituitary, stimulating GnRH release which is followed by the
preovulatory surge of LH during the afternoon of proestrus.
Like sexually differentiated structures and behaviors, regulation of gonadotropin
secretion in adult rats also is influenced by the hormones present during the critical period.
Transplantation of testes into newborn female rats has resulted in tonic LH release in adults,
inducing permanent anovulatory syndrome. Similar results have been observed with early
postnatal treatment of aromatizable androgen or estrogen (Gorski and Wagner, 1965; Dohler,
1991). Male rats that were orchidectomized in utero prior to birth or within 24 hours after
birth showed the capacity to display steroid-induced LH surges (McPherson et al., 1982;
Wieland and Barraclough, 1984; Corbier, 1985). Therefore, these early orchidectomized rats
appear to be feminized with respect to the regulation of LH. Perinatal exposure to cocaine,
since it has been shown to reduce hypothalamic uptake of steroids, may alter LH regulation
via a mechanism similar to that by which it alters sexually differentiated structures and
behaviors.
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The role of neurotransmitters in sexual differentiation of the brain:
The evidence presented thus far shows the strong influence hormones have on
sexually differentiated structures, behaviors, and physiology during the critical period.
Another important aspect of sexual differentiation which has not been discussed up to this
point is the role of neurotransmitters (NTs). Lauder suggests that NTs involved in certain
adult brain functions are probably the same NTs that direct fetal development of the
structures that mediate those brain functions (Lauder, 1983). Therefore, manipulation ofNTs
during the critical period would be expected to alter normal sexual differentiation. Studies
have shown that steroids can influence the NT content in brains, and NTs can modulate
actions of steroids by influencing the number of steroid receptors (Dohler, 1991 ). Therefore,
it appears that steroids and NTs are involved in a complex interaction.
Researchers have shown that manipulation of NTs during the critical period can alter
normally sexually differentiated structures, behaviors, and functions. For example, pregnant
rats treated with haloperidol, an antagonist of DA, gave birth to male offspring that exhibited
reduced mounting behavior as adults (Dohler, 1991). Early postnatal treatment with Ltryptophan, a 5-HT precursor, inhibited expression of lordosis behavior in adult females
(Dohler, 1991). Early postnatal stimulation of

p2-adrenergic

receptors with salbutomal

caused the volume of the SDN-POA to increase in both females and males (Dohler, 1991).
Early postnatal treatment with isoprenaline, an agonist of the P-adrenergic receptors, reduced
the steroid-induced release of LH in females (Jarzab et al., 1989). Therefore, alterations in
the activity of NE, 5-HT, and DA can alter normal sexual differentiation of the brain. Since
these are the same NTs affected by cocaine, perinatal exposure to cocaine may alter normal
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sexual differentiation of the brain.

Effects of cocaine on sexual differentiation of the brain:
Studies have been conducted concerning the effects of cocame on sexual
differentiation of the brain. Dow-Edwards has shown that glucose utilization, a measure of
metabolic activity, is sexually differentiated within certain areas of the brain of rats. For
example, the MPOA in brains of male rats utilizes greater amounts of glucose than the
MPOA in females. Sexual differentiation of this structure was altered by prenatal exposure
to cocaine. In cocaine-treated males, many areas of the hypothalamus, including the MPOA
and periventricular nucleus, had reduced amounts of glucose utilization compared to control
males (Dow-Edwards et al., 1990). Furthermore, when compared to a previous study done
in females, glucose utilization within the MPOA in the cocaine-treated males was
comparable to that in normal and cocaine-treated females (Dow-Edwards, 1988). This
suggests that cocaine may demasculinize the brains of males with respect to glucose
utilization.
Raum et al. have shown that prenatal exposure to cocaine reduced hypothalamic
uptake of estradiol, the masculinizing hormone. They also have shown that perinatal
exposure to cocaine reduced scent-marking behavior typical of males with no effect on this
behavior in females (Raum et al., 1990). Therefore, reduced availability of estradiol may be
sufficient to prevent development of male-like patterns.

Furthermore, Raum and his

colleagues previously had shown that neonatal stimulation with

~-adrenergic

agonists also

can reduce nuclear uptake of estradiol, suggesting cocaine's potential mechanism of action
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(Raum et al., 1984).
Studies have shown that prenatal exposure to cocaine also can reduce a femaletypical behavior, lordosis. Vathy et al. (1993) observed reduced lordosis behavior in
prenatally cocaine-treated females when compared to control females. Adult male rats that
were prenatally cocaine-treated exhibited increased male sexual behavior (mounting and
intromission) when compared to control males. This observation is difficult to interpret
because increased male sexual behavior may imply increased development of male-like
patterns, an interpretation inconsistent with the finding of Raum et al. (1990). It also may
suggest that cocaine-treated males need greater stimulation to achieve ejaculation, therefore
implying demasculinization.

Vathy et al. also observed no differences with respect to

estrous cyclicity between cocaine- and saline-treated females (Vathy et al., 1993).
Another sex-dependent difference shown to be affected by prenatal exposure to
cocaine is responsiveness to cocaine itself. In adult rats, there is an increase in certain
locomotor activities after acute exposure to cocaine. Females have been shown to exhibit
greater activation than males at any given dose. Miller and Seidler have shown that prenatal
exposure to cocaine eliminates this sexually differentiated responsiveness. Cocaine-treated
females exhibited reduced activition compared to that in control females. The activity level
was comparable to that of control and cocaine-treated males, suggesting a defeminizing
effect (Miller Seidler, 1994).
Exposure to cocaine during the critical period appears to alter normal sexual
differentiation of the brain. Research suggests that the effect of cocaine is mediated through
altered levels ofNTs, which may, directly or indirectly, alter the action of steroids. Exposure
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to cocaine during the critical period for sexual differentiation has altered sex-dependent
behaviors and certain physiological functions. Therefore, it seems likely that perinatal
exposure to cocaine would alter LH regulation, a highly sexually differentiated process.
Although Vathy et al. (1993) have shown no effect of prenatal exposure to cocaine on
estrous cyclicity, they did not test effects of cocaine on LH regulation in males or the degree
to which LR-surges could be induced in females. Studies conducted by Raum et al. (1990)
and Dow-Edwards (1988) suggest that cocaine may prevent the development of male-like
patterns and possibly induce female-like patterns in males. Studies conducted by Vathy et
al. (1993) and Miller and Seidler (1994) suggest that cocaine may prevent the development

of female-like patterns and possibly induce male-like patterns in females. Therefore, the
purpose of my experiments was to test the hypothesis that perinatal exposure to cocaine
during the critical period of sexual differentiation of the brain will alter normal sexually
differentiated gonadotropin regulation. Specifically, I hypothesized that males would exhibit
steroid-induced LH release and females would exhibit either normal steroid-induced LH
release or reduced levels of LH.

CHAPTER II
MATERIALS AND METHODS
Experimental Design

The purpose of this experiment was to test the hypothesis that perinatal exposure to
cocaine during the critical period for sexual differentiation of the rat brain interferes with
regulation of LR, a highly sexually differentiated process. I hypothesized that LR-surges
would be induced in males and LR-surges would either decrease in magnitude or remain the
same in females. It has already been demonstrated that some behaviors that are male-specific
in rats are reduced in frequency in males perinatally exposed to cocaine (Raum et al., 1990).
It has also been demonstrated that prenatal exposure to cocaine can inhibit sexual behavior

in adult females (Vathy et al., 1993). I proposed to study another trait that is sexually
differentiated: regulation of the gonadotropin LR.
An important component in regulation of LR is the neurotransmitter system that
governs secretion of GnRH from the hypothalamus. It has been suggested that NTs that are
important for particular functions in adults are also important for correct embryonic
development of the parts of the brain that regulate those functions (Lauder, 1983). Thus, the
NTs important for gonadotropin regulation in adults may also be important for correct
development of the brain areas that regulate gonadotropin release (Kalra and Kalra, 1983;
Barraclough, 1994). Studies have shown that manipulating adrenergic and serotoninergic
18
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systems during the critical period for sexual differentiation of the brain can alter normal
regulation of gonadotropins in adult rats ( Jarzab et al., 1989; Dohler et al., 1991; Dohler,
1991). Cocaine is known to inhibit reuptake ofNTs that regulate gonadotropin release in
adults. I hypothesized that perinatal exposure to cocaine would alter development of the
parts of the brain that control gonadotropin release.
The experimental approach was to treat some rats perinatally with cocame,
gonadectomize them after maturity, inject estradiol and progesterone, cannulate to allow
repeated blood sample removal, and measure LH levels. Normal females demonstrate highamplitude LH surges in response to sequential injections of estradiol and progesterone, and
normal males do not.

Since regulation of LH is highly sexually differentiated, this

measurement of LH response to steroid treatment should distinguish clearly between malelike and female-like endocrine function of the rat brains perinatally exposed to cocaine, and
should detect any differences from the responses of normal (untreated) controls.
If cocaine-treated males show an LH surge, I would interpret the result to mean that

cocaine treatment prevented the normal differentiation of the parts of the brain responsible
for the male-typical pattern of regulation.

This result would be consistent with my

hypothesis that perinatal treatment of male rats with cocaine will prevent normal LH
regulation in their brains. Raum et al. have shown that neonatal stimulation with Padrenergic agonists or prenatal exposure to cocaine can reduce nuclear content of estradiol
(Raum et al., 1984, 1990). NE is a P-receptor stimulator; therefore, increases in NE
concentrations or hyperavailability within the synaptic cleft due to perinatal exposure to
cocaine may be the mechanism by which cocaine mediates this action. It was previously
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mentioned that estradiol is the masculinizing hormone. Thus, reduced availability of
estradiol may be sufficient to prevent development of male-like patterns.
The magnitude of the LH surge may also depend on the magnitude of the reduction
in estradiol content. The reduced availability of estradiol may be sufficient to prevent
development of male-like patterns but may not be sufficient to feminize the brain fully.
Thus, males perinatally exposed to cocaine may exhibit only small LH surges.

If cocaine-treated males show a normal response, that is, no generation of an LHsurge in response to estradiol treatment, I would interpret the result to mean that cocaine does
not affect differentiation of the parts of the brain responsible for normal male regulation of
the pattern of LH or it may be possible that I have missed the critical period. Gorski has
recently shown that the SDN-POA of the rat brain can still be influenced by endogenous
steroid up to postnatal day 29, suggesting a longer critical period that can extend beyond a
few days postnatally (Davis et al., 1995).
Since the majority of evidence suggests that perinatal exposure to cocaine appears
to be blockage of masculinization, I expected no difference between treated and control
females; both were predicted to show LH surges after injection of estradiol and progesterone.

If cocaine-treated females exhibit no steroid-induced LH surge, I would interpret the result
to mean that perinatal exposure to cocaine altered differentiation of the areas of the brain
responsible for normal female regulation of LH. This could happen if perinatal exposure to
cocaine depleted NTs, particularly NE. Jarzab et al. suggested that p-adrenergic stimulation
by NE causes feminization (Jarzab et al., 1987). Depletion of NE would reduce P-receptor
stimulation, which would, according to this hypothesis, result in a lack of feminization.
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Thus, cocaine-treated females would exhibit no steroid-induced LH surge. Evidence to
support the defeminizing effect of cocaine has been given by Vathy et al. (1993), who
showed that lordosis behavior was reduced in females prenatally exposed to cocaine.
If cocaine-treated females exhibit intensified LH surges compared to controls, I

would interpret the result to mean that perinatal exposure to cocaine hyperfeminized female
rats. This would be consistent with the hypothesized outcome for males, in which LH surges
are induced in males, because it would suggest that sexual differentiation of the brain had
been altered toward feminization in both males and females. Research has shown that
manipulating NTs during the critical period can hyperfeminize females with respect to the
LH surge. Neonatal inhibition of a-adrenergic neurotransmission with prazosin, an a 1antagonist, or yohimbine, an a 2-antagonist, has been shown to potentiate LH surges in adult
females (Jarzab et al., 1987; Dohler et al., 1991).
The hyperavailability and depletion of NTs appear to be contradictory mechanisms.
The availability of NTs during treatment may depend on the amount of exposure to cocaine.
It seems logical that at higher doses of cocaine one would expect the depletion of NTs to

occur because homeostatic regulation would be unable to compensate for the ability of
cocaine to block reuptake. Lower doses of cocaine may not be sufficient to out-compete the
brain's homeostatic mechanisms for maintenance of normal NT levels. It is interesting to
note that some effects of cocaine appear at low doses, and at higher doses the response
disappears. For example, at low doses of cocaine scent-marking behavior was reduced in
male rats, and at higher dose of cocaine scent-marking was normal (Raum et al., 1990). My
experimental design employed three different doses of cocaine. Therefore, I may have either
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depletion or enhancement ofNTs but only one at any given dose.

Materials and Reagents

Materials used during cannulation included: silicon tubing (#306-913; Baxter
Scientific Products Division, McGraw Park, IL; i.d. 0.025in., o.d. 0.047 in.), Intramedic
polyethylene tubing (#95452; Clay Adams, Parsippany, NJ; i.d. 0.58in., o.d. 0.965in.), and
silk suture (#51-7706; Harvard Apparatus, S. Natick, MA). All animals were anesthetized
with methoxyflurane (Metofane, Pitman-Moore, Mundelein, IL).
Radioimmunoassays (RIAs) for luteinizing hormone were performed according to
standard procedures. RIA reagents were obtained from the National Hormone and Pituitary
Program of the National Institute of Diabetes and Digestive and Kidney Diseases. The
current reference preparation for LH was used (NIH-rLH-RP-3). Iodination-grade LH was
a gift from Dr. Leo E. Reichert, Jr., of Albany Medical College. LH was radioiodinated
according to the chloramine T method. Intra-assay and inter-assay coefficients of variation
for LH were 15.8% and 32.4% respectively. To eliminate inter-assay variability, all samples
were evaluated in one assAy. Upper and lower limits of detectability were 2.2ng/ml and
95ng/ml respectively. Protein A (IgGsorb) was obtained from The Enzyme Center (Malden,
MA).
Steroids used were estradiol benzoate CP-estradiol 3-benzoate; Sigma, St. Louis, MO)
and progesterone (4-pregnene-3,20-dione; Sigma, St. Louis, MO) dissolved in peanut oil at
concentrations of 0.5mg/ml and 25mg/ml, respectively. Cocaine (d-cocaine hydrochloride)
was obtained from the National Institute on Drug Abuse and dissolved in 0.05M phosphate-
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buffered saline (PBS) at a concentration of 15mg/ml.

Gonadectomy
Sexually mature animals were bilaterally ovariectomized or orchidectomized under
methoxyflurane anesthesia. All surgeries and all other aspects of these protocols were
performed according to procedures approved by the Loyola University Chicago Lakeside
Campuses Institutional Animal Care and Use Committee (IACUC). The animal care facility
is accredited by the Animal & Plant Health Inspection Services.

The purpose of

gonadectomizing the animals was to remove the endogenous source of steroid. After two
weeks all animals received an injection of steroid or vehicle. The regimen of injected
steroids served as a standard test of the animal's ability to respond to positive feedback with
an LH surge. Exogenous steroid treatment also enabled me to collect blood samples at
relatively convenient times. Thus, my ability to detect LR-surges was not dependent on the
inherent estrous cycle of female rats, nor was it compromised by the presence of testosterone
in the male rats.

Cannula and Bleeding Rig Preparation
In order to collect blood samples from the same animal at multiple time points,
indwelling atrial cannulae were prepared. Silicon tubing 5cm in length was soaked in
toluene for approximately 3 hours to expand its diameter. Next, one end of a 15cm length
of Intramedic polyethylene (PE) tubing was held near a heat source, creating a flange
approximately lmm in diameter. The PE tubing was then inserted into the expanded Silicon
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tubing until 0.5cm of Silicon tubing was overlapping the flange end the PE tubing. The
cannula was then rinsed with deionized water and allowed to dry.
Cannula plugs were made from sewing pins that were cut to about 1cm in length
using wire cutters. The cut ends of the plugs were filed down to provide a smooth tip that
would not tear the PE tubing when inserted.
To facilitate blood sampling, a bleeding rig was attached to the cannula. The
bleeding rig consisted of a lee syringe, PE tubing, a connector, and a 23 gauge needle with
the bevel removed. The PE tubing was approximately 40cm in length. The connector was
made from the cut end of a 23 gauge needle. The bevel and the cut end were filed, again to
provide a smooth surface. The 23 gauge needle had its bevel cut and filed as well.
Prior to blood collection the bleeding rig was assembled. The syringe was connected
to the cut 23 gauge needle. The needle was connected to one end of the 40cm PE tubing.
The connector was inserted into the other end of the PE tubing. About 15 minutes prior to
the first blood collection the cannula plug was removed, and the unattached end of the
connector was inserted into the cannula.

A separate 1cc syringe was filled with

approximately 150µ1 heparinized saline. At the time of blood collection, approximately
600µ1 blood were collected. The syringe filled with blood was disconnected from the 23
gauge needle. The syringe filled with heparinized saline was connected, and the heparinized
saline was injected. The bleeding rig was disconnected and the cannula plug was reinserted.
For the first collection of blood in the afternoon, the bleeding rig and syringe were left
attached until the next blood collection. After the last blood sample was collected the
bleeding rig was disconnected and the cannula plug was reinserted. All blood samples were
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collected with new syringes. Between all blood samples fresh heparinized saline in new
syringes was always injected.

Cannulation
Before cannulating, the Silicon end of the cannula was beveled 2.8-2.9cm from the
flange with a razor blade. The animal was then anesthetized with methoxyflurane. The rat
was placed on its dorsal surface and its forelimbs secured with tape. Initially, the incision
site was rinsed with ethanol. Using surgical scissors, a 2.0-2.Scm incision was made just
right of the midline in the neck area. The underlying fat and connective tissue were teased
away with fine forceps until the jugular vein was exposed. To separate the vein from the
remaining tissue, a pair of fine forceps in the closed position was inserted underneath the
vein and then released.
To control bleeding from the jugular vein when inserting the cannula, 7cm pieces of
silk were loosely tied at the rostral and caudal ends of the vein. Each ligature had its ends
clamped with a hemostat. To control bleeding, the hemostats were gently pulled until the
sutures became taught, inhibiting blood flow.
Before inserting the cannula, the PE-end of the cannula was inserted into the
unbevelled end of a metal 14 gauge cannula that served as a trochar. Blunt scissors were
then gently pushed into the incision area just under the skin until they reached the dorsal
portion of the neck. The scissors did not penetrate the skin layer at all. This procedure
created a channel through the connective tissue under the skin for the metal cannula to
follow. The blunt scissors were removed and the bevelled end of the metal cannula was
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inserted, following the pathway laid by the scissor. Once the bevelled end reached the back
of the neck, it was used to pierce the skin. The PE portion of the cannula was now
exteriorized behind the neck of the animal, and the trochar drawn through. The cannula was
attached to a 23 gauge needle and a 1cc syringe filled with approximately 500µ1 heparinized
saline. The heparinized saline was injected until it dripped from the Silicon end of the
cannula. The syringe remained connected to the end of the cannula throughout the surgery.
To insert the cannula into the right atrium, a small hole was cut into the jugular vein
using very fine scissors. To ensure a hole was cut, the sutures were loosened at each end of
the vein to allow blood flow through the vein and the hole. The bevelled end of the cannula
was carefully inserted into the jugular until the flange was surrounded by the vein. The
loosely tied ligature controlling the blood flow at the caudal end of the jugular vein was
released from the hemostat and was used to tie the cannula to the vein. The ligature was tied
just above the flange to ensure that the cannula did not slip from the vein. The ligature
controlling the rostral blood flow was also released from the hemostat. The ligature was then
closed at the rostral end. To anchor the cannula another piece of suture was threaded through
muscle or connective tissue and around the cannula. Care was taken not to tie the suture so
tightly that blood flow would be blocked.
A check was done to ensure blood could be drawn before closing the incision. The
plunger on the syringe was pulled back until blood was drawn. The cannula was then
flushed with approximately 150µ1 heparin. Next the incision was closed using a box stitch.
Finally, the excess PE tubing was cut about 2cm above the skin and the cannula plug was
inserted.
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Preliminary Experimental Protocol

To study the effect of perinatal exposure to cocaine on gonadotropin secretion,
particularly LR-surges, I first developed a protocol that would allow me to induce LRsurges in non-cocaine-treated, ovariectomized adult female rats. In previous literature, a
single injection of estradiol benzoate (50µg/250g body weight [bwt]) given subcutaneously
two weeks after ovariectomy was reported to be sufficient to induce LR-surges in adult
female rats whose blood samples were collected in the afternoon 2 days later (Mann and
Barraclough, 1973; Kalra et al., 1973; Legan et al., 1975). Accordingly, I performed the
following preliminary tests.
In all my preliminary experiments, Sprague-Dawley rats were housed under a
12h: 12h light:dark cycle with lights on at 0500h CST. Breeder animals for this experiment
were obtained from Charles River (Wilmington, MA). Most animals from this experiment,
however,

were bred in the laboratory from the breeder animals.

maintained between 22-25°C.

Temperature was

In preliminary experiment 1, 12 rats were bilaterally

ovariectomized under methoxyflurane anesthesia between 1300h and 1500h (day 1). On day
15, 7 animals were subcutaneously injected with a single dose of estradiol benzoate (EB,
50µg/250gbwt) and 5 animals were injected with the vehicle, peanut oil (O. lml/250gbwt).
On day 16, an atrial cannula was inserted according to the procedure described above. On
day 17, blood samples of approximately 600µ1 were collected in l .5ml microtubes at 1OOOh,
1600h, 1700h, and 1800h. The LR surge normally occurs during the afternoon of proestrus
in female rats. Therefore, the afternoon blood samples were collected every hour from
1600h-1800h. A morning blood sample was collected to observe the effect of steroid on
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negative feedback. Blood samples were refrigerated until centrifugation on the following
day. Samples were centrifuged (Biofuge A, American Scientific Products) at 10687g at
room temperature. Serum was aspirated and stored in 2ml polypropylene screw top vials at
-20°C until RIAs were performed. This procedure was unsuccessful in inducing significant
LH surges in steroid-treated animals (see Results, Figure 1).
I speculated that stress induced during cannulation may have prevented me from
successfully inducing significant LH-surges. Therefore, to obtain blood samples from nonstressed animals, I collected trunk blood by decapitation. In preliminary experiment 2, 32
animals were bilaterally ovariectomized under methoxyflurane anesthesia between 1300h
and 1500h (day 1). On day 15, 16 animals received EB and 16 received oil, exactly as in
preliminary experiment 1. On day 17, blood samples were collected by decapitation at
1OOOh, 1530h, 1600h, and 1630h. Each time point included 8 animals, 4 oil-treated and 4
EB-treated. In preliminary experiment 2, the afternoon time points for blood sampling were
slightly different from preliminary experiment 1 because in preliminary experiment 1 and
in a previous experiment conducted in the laboratory (Kefalas and Suter, unpublished), the
steroid-induced LH-surges in animals housed in our facility appeared to occur around 1600h.
Therefore, blood samples were collected at 1600h and one half-hour before and after (1530h
and 1630h). Blood samples were collected in 15ml conical centrifuge tubes and refrigerated
until centrifugation the following day. Samples were centrifuged (Sorvall SC) at 1302g at
4°C. Serum was collected and stored at -20°C until RIAs were performed. This procedure
was also unsuccessful in inducing significant LH surges in the steroid-treated animals (see
Results, Figure 2).
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Since reduction of stress did not result in a successful induction of an LH surge in
preliminary experiment 2, I decided that an injection of EB alone was not an adequate
treatment regimen. Other steroid treatments have been successful in inducing LH surges in
ovariectomized rats. Along with a single dose of EB, an injection of progesterone on the
morning of blood sampling has proven successful in inducing LH surges in ovariectomized
rats. Previous studies have used doses of progesterone ranging from lmg/kgbwt to 5mg per
animal (Brown-Grant, 1973; Kalra et al., 1973; Mann and Barraclough, 1973; Brann et al.,
1991; Bauer-Dantoin et al., 1992).

Preliminary experiment 3 combines data collected from

3 subset experiments which followed a procedure identical to that described in preliminary
experiment 2, except for the additional injection of progesterone on the morning of blood
sampling (day 17). Briefly, animals were gonadectomized on day 1, and 2 weeks later (day
15) the animals were treated with either oil or EB. On the day of blood sampling (day 17),
EB-treated animals were injected with a single dose of progesterone (5mg/250gbwt), and oiltreated animals were given an additional oil injection (0.2ml/250gbwt).
The procedures for the subset experiments in preliminary experiment 3 had minor
differences. First, in subset experiment 3a, due to unforseen circumstances five of the EBtreated animals were not given an injection of progesterone on the morning of blood
sampling (day 17). Blood collections from four of the animals not treated with progesterone
were at the 1600h time point and one was at the 1630h time point. Second, in subset
experiment 3c, I deleted the 1530h time point. In the previous experiments there had not
been elevated LH levels at the 1530h time point, which indicated that the surge would be
better observed during the later time points, 1600h and 1630h. Third, in subset experiment
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3c, I also included male rats. Normal orchidectomized male rats treated with steroid do not
exhibit an LH surge. I included males in this subset experiment to ensure that I would
observe this lack ofLH surges, and that male rats in our laboratory exhibit normal negative
feedback in response to steroid treatment.

Experimental Protocol

Sprague-Dawley rats were housed as previously described. This experiment included
8-11 blocks of rats. Each block consisted of 10 pregnant females. Pregnant females were
obtained by mating nulliparous adult females with adult males. Pregnancy was confirmed
by the presence of sperm in vaginal lavages taken the morning after mating (gestational day 1
[D 1]). Five pregnant females were assigned to 1 of 5 treatment groups: ad libitum control
(ALC), pair-fed control (PFC), 30mg cocaine/kgbwt dose, 15mg cocaine/kgbwt dose, and
7 .5mg cocaine/kgbwt dose. The remaining 5 pregnant females were assigned as untreated
surrogate mothers for the various treatment groups. Fostering all treated and control pups
to surrogate mothers on the day of birth eliminated the possible confounding of effects of
differences in maternal care or lactation, induced by exposing the mother to cocaine, with
direct effects of cocaine on the pups. All surrogates delivered 1-6 days before their assigned
treated mother. The first 2 pregnancies of each block always consisted of the 30mg/kgbwt
cocaine-treated mother and her assigned surrogate in order to permit pair-feeding, described
below. The following pregnancies within the first block were randomly assigned and this
selection order was rotated for the additional blocks.

The order of the first block was

31
30mg/kgbwt, 7.5mg/kgbwt, 15mg/kgbwt, PFC and ALC. The order of the second block was
30mg/kgbwt, 15mg/kgbwt, PFC, ALC and 7.5mg/kgbwt, and the rotation of the order of
treatments continued in this manner throughout the remaining blocks.
Treatment with cocaine has been shown to reduce nutritional intake in rats (Church

et al., 1990b), and the amount of nutritional intake appears to be inversely related to the dose
of cocaine given. Therefore, to account for any confounding effects of undemutrition that
might accompany treatment, animals in the PFC-, 7.5mg/kgbwt-, and 15mg/kgbwt-groups
received exactly the amount of food and water the 30mg/kgbwt-animal in that block ate and
drank on that day of pregnancy. The first pregnant animal in each block was always assigned
to the 30mg/kgbwt-group to monitor its feeding habits, which determined the amount of food
and water the PFC-animal and the two other cocaine-treated animals would receive in that
particular block. The ALC-animals were allowed to eat and drink as much as they wanted.
The purpose of the ALC-group was to observe effects that might be due to nutrition rather
than cocaine, which would be evident in any differences between the ALC-group and the
PFC-group.
The feeding habits of the ALC-animals were monitored and later compared to the
feeding habits of the 30mg/kgbwt-animals. Food and water consumption for the ALC- and
30mg/kgbwt-groups were monitored from gestational day 15 (D15) up until delivery (D23).
This time frame coincided with the time period of injection of cocaine or PBS into the
pregnant animals. I also monitored gestational weight gain from D 15 to delivery for all
treatment groups.
A subcutaneous dose of 30mg/kgbwt produces plasma levels of cocaine that mimic
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plasma levels in human addicts, and that dose has been shown to alter neurobehavioral
development (Seidler et al., 1995). In previous literature my highest dose, 30mg/kgbwt, has
been shown not to cause obvious teratogenic effects or an increase in the mortality of rat
pups. Animals injected with doses greater than 30mg/kgbwt had a higher incidence of
abruptio placentae, fetal edema, and cephalic hemorrhage than control animals (Church et
al., l 990a, b; Dow-Edwards, 1988). Observing morphological abnormalities such as these

was not the purpose of this experiment. Cocaine is known to have opposite effects at
different doses in some cases, so to ensure that the effective range was spanned I included
two lower doses of cocaine (15- and 7.5mg/kgbwt). My lowest dose is similar to the low
dose used by Raum et al. (1990), who observed significant effects on male behavior.
Including several dose levels was designed to allow me to observe possible effects of
hyperavailability or depletion of NTs.
Daily subcutaneous injections of cocaine or vehicle (PBS) were given on DIS
through D2 l of gestation. Cocaine or PBS was also given daily to the pups on postnatal day
2 (pnd2, one day after birth) up until pndl 0. The dose of cocaine per unit body weight given
to each pup was the same as that given to its mother. The critical period for sexual
differentiation of the brain in rats occurs between D 15 of gestation and the first few days of
postnatal life (Lauder, 1983; Jarzab et al., 1987; Raum et al., 1990). Therefore, by prenatally
and postnatally exposing the pups to cocaine, I was confident that I was spanning the entire
critical period for sexual differentiation of the brain.
On the day of birth the litters were culled to ten pups (five females and five males)
and fostered to a surrogate mother. If there were not ten pups in the litter, I considered the
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acceptable lower limit to be eight pups. I attempted to keep the number of males and females
approximately equal in each litter, but this was not always possible. Litters were culled to
8-10 pups to reduce variability due to the differences in milk availability and nutritional
intake by the pups. I monitored pup weight gain from pndl up to pndlO. All additional pups
from the cocaine-treated groups were sacrificed. Some pups from the surrogate mothers and
ALC-mothers were transferred to other experiments.
On pndl (day of birth), I recorded the size of the litter, total weight of the litter by
sex, and sex ratio. These measurements were taken to observe possible gross effects of
cocaine on the outcome of pregnancy. I also measured the anogenital distance (AGD) of
each pup to monitor a simple sexually differentiated phenotype. The AGD was measured
as the distance between the anus and the genital papilla and was measured using vernier
calipers.
At pnd21, all pups were weaned from their mothers, and female and male siblings
were housed in separate cages. I again recorded weight of the litter by sex and the anogenital
distance of each pup. On pnd45, housing density was reduced to 2-3 animals per cage. For
some groups, reducing the housing density at an earlier date would have been preferable due
to the rapid growth of certain animals. In the interest of uniformity of the protocol among
all experimental animals, however, housing density was always reduced on pnd45. Between
pnd45 and pnd60, daily vaginal lavages were taken from female rats to ensure that any effect
seen on LH levels in females was due to treatment of cocaine and not due to females with
abnormal estrous cycles. To expose all rats to equal handling time, male rats were also
handled in a fashion that simulated that involved in a vaginal lavage between pnd45 and

34
pnd60.
At pnd 60, the sexually mature rats were bilaterally gonadectomized. At pnd74, 3
males and 3 females were injected with EB (50µg/250gbwt) between 0900h and l lOOh. The
remaining rats (2 males and 2 females) were injected with peanut oil (O. lml/250gbwt). At
pnd76, the day blood samples were taken, EB-treated rats were injected with progesterone
(5mg/250gbwt) between 0800h and 0900h. Oil-treated rats received another injection of
peanut oil (0.2ml/250gbwt) between 0800h and 0900h. If there were not 10 pups in a litter,
I attempted to have at least 2 males and 2 females injected with steroids and at least 2 males
and 2 females injected with oil. If this was not possible, an additional litter of the same
treatment was later created to fill in the missing animals.
Blood samples were collected by decapitation at two time points, 1OOOh and 1630h.
Each time point included at least one male and one female steroid-treated animal and also
one male and one female oil-treated animal. If any time point had sibling animals of the
same sex and treatment, I averaged the results of the duplicates to avoid pseudoreplication.
Samples were collected and assayed for LH exactly as in preliminary experiment 3. A time
line of the experimental protocol is included (Diagram 2).

Statistical Analysis
Hormone data from preliminary experiment 1 and maternal and pup weight gain, and
daily food and water consumption from the main experiment were analyzed using two-way
analysis of variance (ANOVA) with repeated measures. The main effects were treatment and
time. AGDs on pndl and pnd21 were analyzed using two-way ANOVA with treatment and
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sex as the main effects. Preliminary experiments 2 and 3, and hormone data from ALC-,
PFC-, 30mg/kg-, 15mg/kg-, and 7.5mg/kg-groups were analyzed using two-way ANOVA
with treatment and time as the main effects. Total food and water consumption, litter size,
birth weight, and sex ratio presented as percent female were analyzed using one-way
ANOVA with treatment as the main effect. When a significant F-value was obtained for a
main effect, Tukey's post-hoc tests determined significant differences between specific
groups within the ANOVA. Data that did not meet the assumptions of ANOV A were
transformed accordingly. If the data still did not meet the assumptions of ANOVA, the data
were analyzed using the appropriate non-parametric tests. Differences with p-values < 0.05
were considered statistically significant.

Sex ratios of the offspring from the various

treatment groups were analyzed using a chi-square test. Cyclicity data were analyzed using
a Kruskal-Wallis Test.
To determine a minimal sample size that would enable me to detect a possible LHsurge in males or to detect possible differences in LR-surges between different females, I
performed a power analysis. The following equation was used:

d
n
o2

=detectable difference between [LH] values in different treatment groups (ng/ml)
=sample size
=variance from a sample population
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<J>- 1(p) =under a normal distribution at a power of 0.83 for a significance level, a., of 0.05
Table 3, Column A (Rosner, 1990)
tu
=under at-distribution at a. level of 0.05; degrees of freedom df=N-k
Table 5 (Rosner, 1990)
N=total number of rats
k=number of treatment groups

Before I determined my sample size I had already collected blood samples from 199 animals:
99 males and 100 females. I measured LH levels from these samples via RIA, and used the
variance of these measurements as an estimate of o 2 •
To determine the minimal sample size that would enable me to detect a significant
LH surge in cocaine-treated males, I first chose a value of 1Ong/ml for d. This meant I
wanted to be able to declare as significant a difference of 1Ong/ml between treatment groups.
The value of o 2 is the mean square error term (M.S.E.) from the statistical analysis of my
sample population (o2=43). The value of <I> (p) with a p value of 0.83 under a normal
distribution equaled 0.96. The tu-value at t.os under a t-distribution with df=79 equaled
1.671. My degrees of freedom were equal to 79 because I had 99 blood samples from males
(N=99), and I had 5 treatment groups, 2 steroid-treatments per cocaine-treatment group, and
2 time points within each steroid-treatment group (k=5x2x2). Since I expected the LH value
in the afternoon for some of the treatment groups to surge I needed only to concern myself
with a one-sided distribution in this case. Solving for n, I calculated a sample size equal to
6. Therefore, to be able to declare a minimal difference of 1Ong/ml between my treatment
groups as significant, I would need a sample size of 6 males for each treatment group.
To determine a sample size that would allow me to detect differences in LH surge
values for the females between treatment groups, I used the same equation as before with a
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slightly different approach. I decided to calculate the value of d given a certain sample size
that I predetermined. I chose my sample size to equal 8. From the data collected on 100
females I obtained a a 2=0.0571. The M.S.E. was much lower than the male M.S.E. because
the female data were log-transformed. The variance of the raw data from the females was
not homogenous, which is an assumption that needs to be fulfilled when using ANOV A.
Therefore, I log-transformed the data. Since I could not anticipate whether the female LH
surge value would increase or decrease, I obtained a two-sided tu-value at t 0 .025 with df=80
(N=lOO, k=20) (to. 025 =2). Solving ford I got a value equal to 0.354 which is the log value.
Therefore, I needed to take the antilog ofthis value which equaled 2.25. This value does not
mean I can detect differences as small as 2.25ng/ml. It meant that if I had a mean equal to
50ng/ml, I would be able to detect a difference that was approximately lower than half the
value of 50ng/ml or greater than twice the value of 50ng/ml, 25ng/ml and 1OOng/ml
respectively. Satisfied with my ability to detect significant differences at these levels I
determined a sample size of 8 to be sufficiently large. Although I determined a sample size
of 6 from my male data, the power analysis for the female data determined a larger minimal
sample size of 8.

CHAPTER III
RESULTS
Preliminary Experiment 1

To study the effect of perinatal exposure to cocaine on LR secretion, I first developed
a protocol that would allow me to induce LR surges in untreated, ovariectomized adult
female rats. To collect serial blood samples from single animals in preliminary experiment
1, I cannulated my animals one day after injection of EB and one day prior to blood
collection. LR values for control (vehicle-injected) animals ranged from 12-21ng/ml (Figure
1. The y-axes in all figures related to the preliminary experiments were set to the same value
in order to facilitate comparisons between subsets of data.). The data were not normally
distributed (p<0.05) and demonstrated heterogeneous variances (p<0.05). The normal
probability plot displayed a logarithmic pattern and therefore the data were log-transformed.
The transformed data were normally distributed and had homogeneous variance. LR levels
in EB-treated animals were not significantly different from those in control animals (p=0.19).
There was a significant effect of time (p=0.001). Tukey's post hoc test indicated that the
1600h time point was significantly different from the lOOOh and 1700h time points (p<0.05).
The significant difference among time points, however, is not indicative of an LR-surge.
Significant LR-surges would be evident as a significant treatment x time interaction, with
a.m. values from EB-treated animals lower than a.m. values from oil-treated animals, and
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Figure 1. Preliminary Experiment 1. Effect of EB on LH in ovariectomized adult female
rats. Serial blood samples were collected via cannulation of the right jugular vein. There
was no significant main effect of treatment (F 1,7= 1.10, p=0.19). There was a significant main
effect of time (F 3,21 =8.81, p=0.001). Times labeled with different letters are significantly
different from each other. There was no significant treatment x time interaction (f 3,21 =1.53,
p=0.24). Each bar represents the mean±S.E.M. of 4 to 6 animals.
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with p.m. values from EB-treated animals higher than p.m. values from oil-treated animals.
There was no significant treatment x time interaction (p=0.24). Therefore, a single injection
of EB (50ug/250gbwt) two weeks after ovariectomy was unsuccessful in inducing significant
LH surges in EB-treated animals.

Preliminary Experiment 2

I speculated that stress during the cannulation procedure prevented me from
successfully inducing significant LH surges in preliminary experiment 1. To obtain blood
samples from non-stressed animals, I collected trunk blood by decapitation in preliminary
experiment 2. The disadvantage of this procedure as compared to blood collection via a
cannula was the increased number of animals used. The advantages of this procedure were
the reduced stress on the animals prior to the collection of blood and the increased volume
of serum collected. From preliminary experiment 1 and previous experiments performed in
this laboratory (Kefalas and Suter, unpublished), I knew that LH surges would most likely
occur around 1600h. Therefore, I collected p.m. blood samples at 1530h, 1600h, and 1630h.
The data satisfied the assumptions of ANOVA and therefore were not transformed. LH
values for control animals ranged from 8-13ng/ml (Figure 2). LH levels in EB-treated
animals were not significantly different from those in control animals (p=0.73). There was
also no significant effect of time (p=0.11) nor a significant treatment x time interaction
(p=0.39). Therefore, this procedure was also unsuccessful in inducing significant LH surges
in EB-treated animals.
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Figure 2. Preliminary Experiment 2. Effect of EB on LH in ovariectomized adult female
rats. Trunk blood samples were collected via decapitation. There was no significant main
effect of treatment (F 1,6=0.14, p=O. 73). There was no significant main effect of time
(F 3, 18=2.33, p=0.11 ). There was also no significant treatment x time interaction (F 3, 18 =1.06,
p=0.39). Each bar represents the mean±S.E.M. of 4 animals.
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Preliminary Experiment 3 (females)
Other researchers have been able to induce LH surges in ovariectomized adult female
rats by giving not only an injection of EB but also an injection of progesterone. To test the
efficacy of the addition of an injection of progesterone to my treatment regimen, I followed
the protocol of preliminary experiment 2 exactly, except that steroid-treated animals received
an injection of progesterone (5mg/250gbwt) on the morning of blood sampling. Control
animals received vehicle injections. LH values for the female oil-treated control animals for
blood samples collected in the morning and afternoon ranged from 15-20ng/ml (Figure 3).
The data did not satisfy the assumptions of normality (p<0.001) or homogeneity of variance
(p<0.001). Plotted residuals displayed a sigmoidal pattern; therefore the data were squareroot transformed.

Although the transformation resulted in data that were normally

distributed, the transformation was unsuccessful in producing variances that were
homogeneous (p<0.001); therefore the appropriate non-parametric test was used, therefore
the data were analyzed using Mann-Whitney U tests. In the morning, steroid-treated LH
levels were significantly lower than oil-treated LH levels (p=0.013). In the afternoon, LH
levels in steroid-treated females were significantly higher than in the oil-treated females
(p=0.004). The data from this experiment demonstrate that I was successful in producing
steroid-induced LH surges in ovariectomized adult female rats.
Although there were highly significant treatment effects in the morning and in the
afternoon samples for preliminary experiment 3, each subset of experiments analyzed
individually did not yield significant differences, teaching me the importance of a
sufficiently large sample size. Confident I could induce an LH surge in steroid-treated, non-
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Figure 3. Preliminary Experiment 3 (female). Effect of combined treatment with EB and
P on LH in ovariectomized adult female rats. Trunk blood samples were collected via
decapitation. *There was a significant main effect of treatment at the 1OOOh time point
(p=0.013). There was also a highly significant main effect of treatment for the combined
afternoon time points (p=0.004). Each bar represents the mean±S.E.M. of 8 to 12 animals.
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cocaine-treated females, I needed to calculate the minimum sample size that would enable
me to detect an LH surge in males or to detect a difference in LH surges of females from
different treatment groups. To do this I performed a power analysis that produced a sample
size of 8 (see statistical analysis section of the Materials and Methods)

Preliminary Experiment 3 (males)
To ensure that orchidectomized adult male rats in our laboratory exhibit normal
negative feedback responses to treatment with steroid, I orchidectomized adult rats and
steroid-treated them two weeks later. LH values for oil-treated males ranged from 1725ng/ml (Figure 4). The data did not satisfy the assumptions of normality (p<0.001) or
homogeneity of variance (p=0.001). The normal probability plot displayed a logarithmic
pattern, and therefore the data were log-transformed.

The transformation resulted in

normally distributed data and variances that were homogeneous. There was a highly
significant main effect of treatment (p<0.001). Oil-treated animals had LH values that were
approximately four-fold higher than those of steroid-treated animals at all time points. There
was no significant effect of time (p=0.75). There also was no significant treatment x time
interaction (p=0.40). These data allowed me to conclude that the male rats did exhibit
normal negative feedback in response to the steroid treatment.
Since I was successful in producing significant LH surges in steroid-treated females
and my control males exhibited normal negative feedback, I proceeded with my main
experiment. The following results are from the main experiment. It should be noted that the
sample sizes within groups were not always 8. The reason for this was the loss of pups
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Figure 4. Preliminary Experiment 3 (male). Effect of combined treatment with EB and P
on LH in orchidectomized adult males. Trunk blood samples were collected via
decapitation. *There was a highly significant main effect of treatment (F l,1 8=46.05,
p<0.001). There was no significant main effect of time (F 2, 18=0.36, p=0.75). There was no
significant treatment x time interaction (F 2, 18=0.97, p=0.40). Each bar represents the
mean±S.E.M. of 4 animals.
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during the experiment. In order to have a sample size of at least eight, I needed to have
make-up litters. The loss of pups occurred in a number of the treatment groups, but seemed
to be more problematic within my 30mg/kgbwt group. Therefore, the additional make-up
litters caused my sample size to exceed 8 in some cases.

Food and water consumption

Treatment with cocaine has been shown to reduce nutritional intake (Church et al.,
1990b). I compared the amounts of food and water consumed by the ALC-group and the
30mg/kgbwt-group. There was a highly statistical significant main effect of treatment
(p<0.001) for the total amount of food consumption as a percent of body weight from D15
to D22 (Figure 5). The 30mg/kgbwt group ate approximately 10% less than the ALC group.
There was no significant difference in water consumption between the 30mg/kgbwt- and
ALC-groups (p=0.68).
I also wanted to see if there was a difference between the two groups in the pattern
of food and water consumption. I therefore analyzed daily food and water consumption from
D15 to D22. In Figure 6, the daily food intake as a percent of body weight from D15 to D22
is shown. All percent values were below 10%; therefore the data were arcsin square-root
transformed.

The transformed data did satisfy the assumption of normality but not

homogeneity of variance (p<0.05).

Specifically, D16, D20 and D21 demonstrated

heterogeneous variance, whereas data from the other five days had homogenous variances.
The 2-way ANOVA indicated a highly significant treatment x time interaction (p=0.001),
indicating that the ALC-group and the 30mg/kgbwt-group did have different patterns of food
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Figure 5. Total food and water intake from D15 to D22 measured as a precent of weight.
*The 30mg/kgbwt group consumed less food than the ALC group, therefore, there was a
significant main effect of treatment for the total amount of food consumed (F 1,25 = 18. 93,
p<0.001). There was no significant main effect of treatment for the total amount of water
consumed (F 1,25=0.18, p=0.68). Each bar represents the mean±S.E.M. of 10 to 17 animals.
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Figure 6. Daily amount of food intake from D 15 to D22 measured as a percent of weight.
There was a significant time x treatment interaction (F 7, 140=3.90, p=0.001). *Subsequent ttests and Mann-Whitney U tests indicated significant differences from D 15 through D 17 and
on Dl9. Each point represents the mean±S.E.M. of 9 to 17 animals.
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consumption. Post hoc tests were performed on each day with treatment as the main effect.
Food consumption on those days with heterogeneous variances were analyzed using the
Mann-Whitney U test; on those days with homogenous variances, post-hoc t-tests were
performed. All p-values from t-tests and Mann-Whitney U tests were adjusted with a
Bonferroni correction factor. The ALC-group consumed significantly more food than the
30mg/kgbwt-group from D15 through Dl 7 and on D19 (p<0.05). On D18 and D20 though
D22, both groups consumed approximately the same amount of food (p>0.05).
I attempted to analyze differences in the pattern of water consumption, but the data
did not satisfy the assumptions of parametric analysis even after transformation.
Furthermore, available non-parametric tests were not appropriate. By inspection of Figure
7, it does not appear there are any differences in the pattern of daily water consumption for
the days measured.

Maternal weight gain

Maternal weight gain, expressed as the percent difference from weight measured on
the morning ofD15, is presented in Figure 8. The data satisfied the assumptions of ANOVA
and therefore were not transformed. There was a significant treatment x time interaction due
to different patterns in weight gain among treatment groups (p<0.001). The ALC-group
gained weight linearly from D15-22 of gestation. The PFC-group, however, gained no
weight for the first 2 days of treatment, and then gained weight throughout the rest of
pregnancy at a rate parallel to the ALC-group. Subsequent 1-way ANOVAs were performed
on each day to better describe the differences observed in Figure 8. At all days measured

51

ALC
30mg/kgbwt

25

--1--::~-d......-

- -

-I--

-:i;
''
''

5

15

16

18
19
20
17
day of pregnancy

21

22

Figure 7. Daily amount of water intake from D 15 to D22 measured as a percent of weight.
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Figure 8. Daily percent increase in maternal weight from D15 to D22. There was a
significant treatment x time interaction (F 24 ,282 =2.48, p<0.001). Separate 1-way ANOVAs
were performed on each day. There was a significant main effect of treatment for every day
measured (p<0.05). Post hoc Tukey's tests indicated the PFC-, 7.5mg/kgbwt-, and 15mg/kgbwt-group were significantly different from the ALC-group throughout all days
measured (p<0.05). The 30mg/kgbwt group was not significantly different from the ALCgroup from D15 up to and including D19 (p>0.05). From D20 up to and including D22, the
30mg/kgbwt group was significantly different from the ALC-group. Each point represents
the mean±S.E.M. of9 to 17 animals.
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there was a significant main effect of treatment after adjusting p-values with a Bonferonni
correction factor (p<0.05). Post hoc Tukey's tests indicated that the animals in the PFCgroup gained significantly less weight than the ALC-group throughout all of the measured
days (p<0.05). The 7.5- and 15-mg/kgbwt group gained weight in a pattern identical to the
PFC-group (p>0.05). The 30mg/kgbwt group exhibited a different pattern, gaining almost
as much weight as the ALC-group for the first 4 days of treatment (p>0.05). In fact,
subsequent analysis indicated the ALC-group was not significantly different from the
30mg/kgbwt group up to and including Dl9. After D19 the 30mg/kgbwt group gained
weight more slowly and was not significantly different from the PFC-group, 7.5- or 15mg/kgbwt groups (p>0.05).
Data were also analyzed without adjusting for starting weights when measurements
began.

Again, the data satisfied the assumptions of ANOVA and therefore were not

transformed. As for the adjusted data, there was a highly significant treatment x time
interaction (p<0.001). Subsequent 1-way ANOVAs were performed for each day measured.
Unlike the case of the adjusted data, there was no significant main effect of treatment for
maternal weights for any of the days measured (p>0.05). There was a highly significant
main effect of time due to the overall increase in weight for all groups throughout gestation
(p<0.001).
Total maternal weight gain also was analyzed using a one-way ANOVA. There was
a highly significant main effect of treatment (p=0.001). Tukey's test showed that the ALCgroup gained more weight than the PFC-group and the cocaine-treated groups, approximately
25g more, but that there was no difference in total weight gain among the PFC-group and the
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cocaine-treated groups. To ensure that differences in total weight gain were not due to
differences in maternal weights at the start of treatment (D 15), maternal weights on D 15
were analyzed using a one-way ANOVA with treatment as the main effect. The data
satisfied the assumptions of normality and homogeneity of variance and therefore were not
transformed. No significant differences were found between treatment groups (p=0.59). To
determine if the lack of significance was biologically real or due to a lack of statistical
power, a power analysis was performed. A power analysis determines the probability of
making a type II error, accepting the null hypothesis when it should be rejected. The P value
calculated from the power analysis was 0.72 which translates into a 72% probability of
correctly rejecting the null hypothesis. Therefore, differences in total weight gain between
the ALC-group and the PFC- and cocaine-treated groups appear to be real and not due to
differences in starting maternal weights on D 15.

Total birth weight, litter size and sex ratio
Figure 9 represents the average weights of the litters at pndl for each treatment
group. The weights ranged between 80-90g. The data satisfied the assumptions of ANOV A
and therefore were not transformed. There was no significant difference between treatment
groups (p=0.60).
The average litter size for each treatment group is shown in Figure 10. The average
size of the litters for all groups was approximately 13 pups. There was no significant main
effect of treatment (p=0.74) The variance was homogeneous, but the data were not normally
distributed (p=O.O 1). The non-transformed data were analyzed due to the robust nature of
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Figure 9. Average total weight of pups delivered at birth (pndl). There was no significant
main effect of treatment (F4A8=0.69, p=0.60). Each bar represents the mean±S.E.M. of 9 to
16 litters.
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Figure 10. Litter size at birth (pndl ). There was no significant main effect of treatment
(F 449 =0.49, p=0.74). Each bar represents the mean±S.E.M. of9 to 16 litters.
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the ANOVA procedure to departures from normality.
To determine if the sex ratio were significantly different from a 1: 1 ratio for each of
the treatment groups, a

x2 test was performed.

The data satisfied the assumptions of

parametric tests and therefore were not transformed. Sex ratios were not significantly
different from a 1: 1 ratio for any of the treatment groups (p>0.05). To determine if any of
the treatment groups were significantly different from each other, sex ratios expressed as%
female were analyzed using a one-way ANOV A. There was no significant main effect of
treatment (p=0.94) (Figure 11).

Pup weight gain

The body weight of each pup was measured daily from pndl-pndlO and also at
pnd21. The average body weights per pup for pndl-pndlO and pnd21 were analyzed using
3-way ANOVA with repeated measures with sex, treatment, and time as the main effects.
The data did not satisfy the assumptions of normality (p<0.05) or homogeneity of variance
(p<0.05). Plotted residuals displayed a logarithmic pattern, and therefore the data were logtransformed. The data still did not statisfy assumptions of normality or homogeneity.
Therefore, pup weights were analyzed separately for males and females and only for pndl,
pnd 10 and pnd21. These data did satisfy assumptions of parametric testing. I analyzed the
data using a 2-way ANOVA with repeated measures with time and treatment as the main
effects. Figure 12 represents the average body weights per pup for each treatment group.
On pndl the average weight of a pup was approximately 6.5g. By pndlO the average pup
weight increased to approximately 20g. Pup weight gain from pnd 1 to pnd21 was not
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Figure 11. Sex ratio expressed as % female. There was no significant main effect of
treatment (F 4,47=0.20, p=0.94). Each bar represents the mean±S.E.M. of 9 to 14 litters.
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significantly different among treatment groups for either sex (males, p=0.85; females,
p=0.50). There also was no significant treatment x time interaction (males, p=0.65; females,
p=0.54). There was a significant main effect of time (p<0.001) for both sexes due to the
overall increase in weight throughout the days measured.

Anogenital Distance
To observe effects of cocaine on a sexually differentiated morphological attribute,
I measured the AGDs at pndl and pnd21. A significant correlation has been found between
weight and AGD, so I adjusted AGD by dividing by the pup weight. At pndl and pnd21,
these adjusted data satisfied the assumptions of ANOVA and therefore were not transformed.
Figure 13 displays adjusted AGDs that were measured at pndl and pnd21. AGDs at
pndl and pnd21 were analyzed separately, using 2-way ANOVA with sex and treatment as
the main effects. At pndl there was a highly significant main effect of sex (p<0.001)
because the males had longer AGDs than the females. There was no significant main effect
of treatment (p=0.68) or treatment x sex interaction (p=0.51) for adjusted AGDs at pndl.
At pnd21, there was a significant treatment x sex interaction (p=0.04) indicating that
the sex difference in AGD varied among treatment groups. The AGD in males was 11 %
greater than in females in the PFC-group, but only 7% greater in the 30mg/kgbwt group.
Separate 1-way ANOVAs were performed on each treatment group with sex as the main
effect. For every group, males had significantly longer AGDs than females (p<0.05) except
for the 30mg/kgbwt group (p=0.06). Separate ANOVAs also were performed on each sex
with treatment as the main effect. Within males and within females, there was no significant
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Figure 13. Anogenital distance adjusted for weights on pndl and pnd21 for male and female
offspring. *For pndl there was no significant main effect of treatment (F 4,96 =0.58, p=0.68).
There was a significant main effect of sex (F 1,96= 1007.34, p<0.001 ). There was no signifcant
treatment x sex interaction (F496=0.83, p=0.51). For pnd21 there was a significant treatment
x sex interaction (F 4,74=2.69, p=0.04). *Separate 1-way ANOVAs for each treatment
indicated significant differences in AGDs between males and females (p<0.05) except for
the 30mg/kgbwt group (p=0.06). Separate 1-way ANOVAs for each sex indicated no
significant differences between treatment groups (p>0.05). Each bar represents the
mean±S.E.M of 8 to 15 litters.
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difference among treatment groups (p>0.05). All p-values for separate 1-way ANOVAs
were adjusted with a Bonferonni correction factor.

Estrous Cyclicity

To ensure that any effect seen on LH levels in females was due to treatment of
cocaine and not due to females with abnormal estrous cycles, I performed vaginal lavages
from pnd45-60. I determined the vaginal cytology from the lavages, and the data were
recorded. Cell types were designated 'l' for leukocytic, 'n' for nucleated, and 'c' for
cornified. Females were cycling normally if they exhibited at least 3 consecutive 4- or 5-day
estrous cycles. Estrous cycles were indicated by the presence of an overnight conversion
from 'c' cells to 'l' cells. There were no significant differences among treatment groups
(p=0.77; data not shown).

LH levels in oil-treated females

After perinatal exposure to cocaine or vehicle, pups were allowed to mature. To
observe effects of perinatal exposure to cocaine on regulation of LH secretion, the adult
female and male rats were gonadectomized and two weeks later treated with either oil or
steroid. LH levels of oil-treated females are graphed in Figure 14. They-axes in all figures
related to LH data were set to the same scale in order to facilitate comparisons between the
different subsets of data.
Although I had two control groups, ALC and PFC, my graphs display only one
control group, the PFC-group. I compared LH levels between the ALC- and PFC-groups
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Figure 14. Effect of perinatal exposure to cocaine on LH secretion in oil-treated
ovariectomized adult female rats. There was no significant main effect of time (F 1,61 =0.77,
p=0.38) or treatment (F 3,61 =0.21, p=0.89). There was also no significant treatment x time
interaction (F 361 =0.22, p=0.88). Each bar represents the mean±S.E.M. of 8 to 10 animals.
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using a two-way ANOVA with treatment and time as the main effects, and found no
significant difference between the two (p=0.22). Therefore, nutrition did not appear to affect
LH values for the oil-treated females. All subsequent comparisons ofLH levels between the
ALC- and PFC-groups used the same statistical analysis.
When analyzing the effect of cocaine on LH regulation I used the appropriate control,
the PFC-group. The PFC-group received treatment identical to the cocaine-treated groups
except for the injection of cocaine. The PFC-group received injections of vehicle (PBS).
The LH values in the morning were approximately 15ng/ml for all groups. The data
satisfied the assumptions of normality and homogeneity of variance and therefore were not
transformed. The LH values in the afternoon were not significantly different from the values
in the morning (p=0.38).

There was also no significant treatment effect (p=0.89) or

treatment x time interaction (p=0.88).

LH levels in steroid-treated females

Female steroid-treated animals all exhibited significant LH surges, indicated by a
significant main effect of time (p<0.001) (Figure 15). The LH values in the morning were
approximately 8ng/ml for all treatment groups. The LH values in the afternoon were
approximately 8-fold higher than in the morning. The data did satisfy the assumption of
homogeneity of variances but were not normally distributed (p<0.001 ). The non-transformed
data were analyzed due to the robust nature of the ANOVA procedure. There was no
significant treatment effect (p=0.36). There was also no significant treatment x time
interaction (p=0.45), indicating that the pattern of low a.m values and high p.m. values had
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Figure 15. Effect of perinatal exposure to cocaine on LH secretion in steroid-treated
ovariectomized adult female rats. *There was a significant main effect of time (F 1,63 =248.7,
p=0.0001). There was no significant main effect of treatment (F363 =1.70, p=0.18) or
treatment x time interaction (F 3,63 =1.27 p=0.29). Each bar represents the mean±S.E.M. of
8 to 11 animals.
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a similar appearance in each treatment group. As for the oil-treated females, the ALC-group
was not statistically different from the PFC-group (p=0.42).

LH levels in oil-treated males

LH levels in oil-treated males are shown in Figure 16. The data did satisfy the
assumption of normality but not homogeneity of variance (p=0.003).

Plotted residuals

displayed a logarithmic pattern, therefore the data were log-transformed.

After the

transformation, the distribution was now not normal (p=0.02), but the variances were
homogenous. Although the data did not satisfy the assumption of normality, transformed
data were analyzed due to the robust nature of the ANOVA procedure. There was a
significant time effect (p<0.001 ). The significance can be attributed to the lower LH values
in the morning than in the afternoon for all treatment groups. The mean LH values in the
morning and afternoon were approximately 14ng/ml and 18ng/ml, respectively. There was
no significant treatment effect (p=0.86) or treatment x time interaction (p=0.22). The ALCgroup for the oil-treated males also was not statistically different from the PFC-group
(p=0.90).

LH levels in steroid-treated males

The data did not satisfy the assumptions of normality (p=0.006) or homogeneity of
variance (p<0.001). Plotted residuals displayed a logarithmic pattern, and therefore the data
were log-transformed. Transformed data were normally distributed, and the variance was
homogeneous. For steroid-treated males there was also a highly significant time effect
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Figure 16. Effect of perinatal exposure to cocaine on LH secretion in oil-treated
orchidectomized adult male rats. *There was a significant main effect of time (F 1,60=13.30,
p=0.0006). There was no significant main effect of treatment (F 3,60=0.52, p=0.67) or
treatment x time interaction (F 3,60=1.14, p=0.34). Each bar represents the mean±S.E.M. of
8 to 10 animals.
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(p<0.001) (Figure 17). The significance can be attributed to the higher LH values in the
morning than in the afternoon for all treatment groups. There was no significant treatment
effect (p=0.50) or treatment x time interaction (p=0.50). The ALC-group and the PFC-group
also were compared in steroid-treated males, and were not significantly different from one
another (p=0.13).
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Figure 17. Effect of perinatal exposure to cocaine on LH secretion in steroid-treated
orchidectomized adult male rats. *There was a significant main effect of time (F 1,61 =32.83,
p<0.001). There was no significant main effect of treatment (F 3,61 =0.80, p=0.50) or treatment
x time interaction (F 3,61 =0.79, p=0.50). Each bar represents the mean±S.E.M of 8 to 11
animals.

CHAPTER4
DISCUSSION
The purpose of this experiment was to study the effects of exposure to cocaine during
the critical period for sexual differentiation of the brain on regulation of LH, a highly
sexually differentiated physiological function. I also was interested in cocaine's effects on
maternal weight gain and nutritional intak, as well as, perinatal effects of cocaine on
offpsring litter size, sex ratio, ano-genital distance, and birth weight and offspring weight
gain. Researchers have shown that treatment with cocaine during the critical period for
sexual differentiation of the brain can alter sexually differentiated behaviors, such as lordosis
(Vathy et al., 1993) and scent-marking (Raum et al., 1990). Researchers have also shown
that prenatal exposure to cocaine can alter sexually differentiated glucose utilization in
certain areas of the brain (Dow-Edwards, 1988; Dow-Edwards et al., 1990). The ability of
cocaine to affect these sexually differentiated processes prompted me to test the hypothesis
that perinatal exposure to cocaine during the critical period for sexual differentiation of the
brain would alter normal sexually differentiated LH regulation. To test my hypothesis I
perinatally exposed rats to cocaine during the critical period for sexual differentiation of the
brain. Male and female cocaine-exposed pups were allowed to grow to sexual maturity and
as adults were then gonadectomized. Animals were then injected with steroids known to be
successful in inducing LH surges in non-cocaine treated ovariectomized adult females.
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Mophological Measurements

The subcutaneous dose of 30mg/kgbwt, the highest I used, produces plasma levels
of cocaine that mimic those in human addicts (Seidler et al., 1995) and has been shown not
to cause teratogenic effects or an increase in the mortality of the pups (Church et al., 1990a,
b: Dow-Edwards, 1988).

To ensure that this dose of cocaine did not cause serious

teratogenic effects in my hands, I measured litter size, total birth weight, and individual pup
weight. Significant differences in these measurements among treatment groups were not
found, nor did I anecdotally observe any morphological abnormalities. Therefore, my results
are in agreement with those of other researchers (Church et al., l 990b; Henderson and
McMillen, 1990).
Researchers have shown that treatment with cocaine reduces nutritional intake.
Therefore, I gave animals in the PFC-, 7.5mg/kgbwt-, and 15mg/kgbwt-groups exactly the
amount of food and water that animals in the 30mg/kgbwt-group ate and drank to account
for any confounding effects of undernutrition. My data clearly indicate that the treatment
of cocaine I administered reduced nutritional intake. Mothers from the ALC-group ate
significantly more food than mothers from the 30mg/kgbwt-group.

I mentioned in the

results that the ALC-groups ate approximately 10% more food than the 30mg/kgbwt-group.
Although, this does not seem like a large amount of nutritional loss, small changes in food
consumption do result in altered physiology. Furthermore, reduced nutritional intake
translated into reduced maternal weight gain during treatment. This reduced maternal weight
gain, however, did not affect litter size or total birth weight. Therefore, the maternal
physiology successfully transferred adequate nutrition to the pups, reducing the weight of
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the mothers.

My results are in agreement with those of other researchers who have

administered doses similar to mine to rats (Church et al., 1990b; Henderson and McMillen,
1990). Low birth weight in human babies prenatally exposed to cocaine is a consistent
finding (Petitti and Coleman, 1990; Lutiger eta!., 1991). I was unable, however, to observe
similar results in my rat pups prenatally exposed to cocaine, suggesting that low birth weight
in human babies maybe due to some factor or combination of factors other than cocaine, such
as multiple drug abuse or a reduced level of prenatal care, or that rats and humans respond
differently to cocaine.
In addition to birth weight, I monitored pup weight gain from pndl-pndlO and once
again at pnd2 l. I did not observe any effect of cocaine on pup weight gain at any of the days
measured. Therefore, cocaine does not appear to delay or impair physical development as
neonates or juveniles.

Again, my results coincide with those of other researchers

administering similar doses of cocaine for similar lengths of time (Church et al., 1990b).
I also measured AGDs of pups and the sex ratio (as determined by AGDs) of the
litters.

Researchers have shown that the steroidal environment influences sexually

differentiated characteristics. The AGD can be altered by altering the hormonal environment
during gestation. For example, the AGD in females can be increased by hormones secreted
by adjacent male siblings within the uterus (Clemens et al., 1978). Therefore, as a simple
(although not necessarily conclusive) indicator of the prenatal hormonal environment, I
measured the sex ratio and AGDs of the offspring. The AGD has been shown to be longer
in males than females at all ages even after correction for differences in body size. Not
surprisingly, at pndl I observed males to have longer AGDs than females. At pnd21,
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however, I did observe a significant treatment x sex interaction. For all treatment groups
males had significantly longer AGDs than females except for the 30mg/kgbwt group, in
which the AGDs were statistically equal between sexes (p=0.06). Although individual
ANOV As indicated no main effect of treatment within a sex, it appeared that the female
animals had AGDs that were as long as the male AGDs within the 30mg/kgbwt group,
suggesting masculinization of this morphological characteristic. Although the p-value of
0.06 approached significance, a power analysis indicated a power>0.99, indicating the
unlikely possibility of not finding a real significance. Furthermore, a recent study by Cutler

et al. (1996) supports my finding. In that study, at pndl AGDs of females prenatally
exposed to cocaine were greater than AGDs of those not exposed. These observations were
evident on pnd I whereas mine were not apparent until pnd2 l. The discrepancy between my
results and those of Cutler et al. in the time of appearance of cocaine's effect on genital
development may partially be explained by the different exposure lengths between the two
studies. Cutler et al. exposed pregnant females from gestational day 8 to 20. I exposed
females later in the gestational period, days 15-22, and further exposed the neonates, from
pnd2 to pndlO. Early exposure to cocaine may have a greater impact on the morphological
development of the ano-genital region. Therefore, cocaine's effect on AGD may have been
more dramatic for pups on pndl for Cutler et al. than for the pups in my experiment. Since
I began cocaine injection on DIS and continued until pndlO, cocaine's effect on AGD in my
study may have been subtle on pndl with no apparent effect until pnd21. The exact
mechanism by which cocaine affects genital development is not known. Cocaine may alter
the neuroendocrine systems which may indirectly interfere with or alter genital development.

74
Cocaine does cause increased levels of DA, which can result in prolactin levels to fall since
DA is inhibitory to prolactin release. And since prolactin does inhibit LH secretion, lower
levels of rolactin may result in higher levels of LH which would stimulated steroid
production (Kalra and Kalra, 1983). Higher levels of testosterone secretion by male fetal
gonads may be sufficient to masculinize the AGD of females.

LH regulation

Oil-treated females had LH levels that did not differ between morning and afternoon.
These results were not surprising since I did not expect to observe an oil-induced LH surge.
The oil-treated control females did not differ from the cocaine-treated females. I also did not
observe LH surges in oil-treated males and the control group did not differ from the cocainetreated groups. I did, however, observe a significant time effect in oil-treated males. LH
levels were greater in the afternoon than in the morning for all treatment groups, suggesting
a diurnal pattern.

Others have observed diurnal variations in LH secretion in non-

orchidectomized males (Dunn et al., 1972; Taya and Igarashi, 1974; Huhtaniemi et al.,
1982). Peak levels of LH were observed at various times but the ranges of time were
generally between late evening and early morning (2300-0300h). Others have also reported
observing an absence of diurnal secretion ofLH in non-orchidectomized (Shin and Kraicer,
1974; McLean et al., 1977; Kalra and Kalra, 1977) and orchidectomized males (Yamamoto

et al., 1970; Henderson et al., 1977). So, it is still not well established whether LH in males
is secreted in a diurnal pattern. I collected blood samples at limited time points, and further
experiments would need to be performed in order to make a more conclusive argument. My

75

data do suggest, however, that a diurnal rhythm of LH exists in males.
I observed normal male-typical regulation of LH in the steroid-treated PFC control
group. Normal sexual differentiation of the male brain renders it unable to respond in a
positive feedback manner to high levels of estrogen with enhanced secretion of LH. Upon
steroid treatment, males in the PFC-group exhibited normal negative feedback. Control
males treated with steroids had lower LH levels in the afternoon compared to the morning,
which can be attributed to the injection of progesterone on the morning of blood sampling.
The control males did not differ from the cocaine-treated males. Therefore, perinatal
exposure to cocaine does not appear to alter regulation of LH in adult male offspring.
Normal females in the PFC-group did exhibit LH surges upon steroid stimulation.
Normal sexual differentiation of the female brain renders it able to respond positively to the
steroid treatment with enhanced secretion of LH late in the afternoon. The cocaine-treated
females responded to the steroid treatment with LH surges that were not significantly
different from the control females. Therefore, perinatal exposure to cocaine does not appear
to alter gonadotropin regulation in adult female rats.
I had hypothesized that masculinization would be blocked in cocaine-treated males,
and thus that steroid-induced LH surges would be demonstrated in orchidectomized cocainetreated males. My reasoning followed two lines of evidence. First, Raum et al. (1990) have
shown that prenatal exposure to cocaine demasculinized at least one male behavior, scentmarking; and Dow-Edwards has shown that prenatal exposure to cocaine demasculinized
glucose utilization in the brains of adult male rats (Dow-Edwards, 1988; Dow-Edwards et

al., 1990). Second, NE, a NT strongly affected by cocaine, is also the same NT involved in
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LH regulation in adults.

Lauder and Krebs (1986) have suggested that NTs direct

embryological development of systems they will control in adulthood.
Adrenergic receptors located on postsynaptic neurons are thought to be involved in
development and sexual differentiation of the brain. Raum et al. (1984) showed that
neonatal stimulation with a P-adrenergic agonist reduced hypothalamic nuclear content of
estradiol, the active hormone involved in masculinization of the brain. Dohler et al. ( 1991)
have also shown that neonatal treatment with a P-agonist, isoprenaline, in males and females
increased steroid-induced adult lordosis behavior compared to controls.

Therefore,

stimulation of P-receptors with exogenous agonists appears to hyperfeminize sexual
behaviors in females, and to feminize the male brain, enabling males to perform femaletypical lordosis behavior in response to steroid treatment. NE is a P-receptor stimulator;
therefore, increases in NE concentrations or hyperavailability within the synaptic cleft due
to perinatal cocaine exposure may also result in reduced estradiol content and at least partial
feminization of the brain. Further studies by Raum et al. (1990) have suggested that prenatal
exposure to cocaine demasculinized at least one male behavior, scent-marking, possibly due
to reduced nuclear uptake of steroids, stimulated by P-receptor activation during the critical
period.
As my results show, LH surges were not steroid-inducible in adult male rats
perinatally exposed to cocaine. Seidler et al. (1995) have recently shown that adrenergic
activity is actually inhibited in rats neonatally treated with the same dose of cocaine used in
my study. Compared to untreated rats, cocaine-treated rats had reduced NE turnover,
expressed as the fraction of NE lost after treatment with a catecholamine synthesis inhibitor.
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If less NE were lost in cocaine-treated animals compared to controls, this would suggest that

adrenergic activity is reduced in the cocaine-treated animals. Therefore,

~-receptors

do not

appear to be hyperstimulated but just the opposite. This finding would suggest that less
feminization, not more, should occur in cocaine-exposed males.
Although the findings by Seidler et al. appear to contradict the findings by Raum et

al., a closer look at the variation in their methods needs to be taken. The length of exposure
to cocaine differed between these two experiments.

Both administered cocaine

subcutaneously, but Raum et al. exposed animals prenatally (D15-D20) as well as postnatally
(pndl-5), and Seidler et al. administered cocaine only postnatally (pndl, pnd7, pnd14, and
pnd21 ).

Another discrepancy is the specificity of the area of the brain in which

measurements were taken. Raum et al. measured nuclear uptake of steroids specifically in
the hypothalamus. Seidler et al. measured fractional turnover of neurotransmitters in the
entire fore brain, which includes the hypothalamus along with other regions of the brain. In
terms of the length of exposure to cocaine, my experimental protocol more closely followed
that of Raum and his colleagues. In addition, I focused on the effect of cocaine on LH
secretion, which is regulated by the hypothalamus. Therefore, conclusions drawn from
Raum et al. seem to be more pertinent to my experiment than those from Seidler et al.
A possible explanation as to why I did not observe steroid-induced LH surges in
males perinatally treated with cocaine has to do with the nature of the surge mechanism. LH
surges can be steroid-induced in normal ovariectomized adult female rats.

Crowley

demonstrated that, prior to the LH surge, a sequential accumulation followed by a decline
in luteinizing hormone-releasing hormone (LHRH) occurs. He also demonstrated an
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increase in turnover rates of NE concomitant with the accumulation of LHRH (Crowley,
1988; Crowley and Kalra, 1994).

LH surges cannot be steroid-induced in normal

orchidectomized adult male rats, and the changes in LHRH and NE triggered by steroid
treatment in females were not observed in similarly treated male rats. Adult ovariectomized
female rats that were neonatally treated with estradiol did not respond to the steroid treatment
as adults; thus, no LH surges were observed. Nevertheless, all the female-typical changes
in LHRH and NE prior to an LH surge were observed in these "masculinized" females.
Therefore, estradiol may be responsible for the uncoupling of excitatory influences of NE
and LHRH from secretion of LH, but some other factor may be responsible for the lack of
adrenergic activity in response to steroidal treatment in males (Crowley and Kalra, 1994).
Crowley suggests these other factors may include testosterone itself or some other nonestrogenic metabolite. The capacity to have LH surges seems to require a number of
necessary aspects and to compromise any one of them disables the entire surge mechanism.
Crowley and Kalra (1994) have shown that although the females neonatally exposed to
estradiol exhibited many aspects of an LH surge in non-treated females, they were unable to
have an LH surge. Therefore, it is possible I was able to feminize some aspects of my
cocaine-treated males, but not all the necessary aspects needed for LH surges. This may
explain why I was unable to induce LH surges in my male rats that were perinatally exposed
to cocaine.
Crowley et al. also bring up an interesting point regarding the exact roles of estrogen
and testosterone in masculinization. If testosterone is responsible for the lack of adrenergic
stimulation upon steroid treatment in males, then estradiol may not be responsible for all
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masculinizing effects during the critical period. I did not gonadectomize my male rats during
the critical period for sexual differentiation of the brain.

Therefore, the presence of

testosterone may have been sufficient to cause a lack of adrenergic stimulation upon steroidal
treatment in adult males. LH surges can be steroid-induced in adult male rats that have been
orchidectomized at birth or shortly after birth (McPherson et al., 1982, Weiland and
Barraclough, 1984, Corbier, 1985). So it is possible to induce LH surges in male rats but it
requires the removal of androgens during the sensitive period of masculinization, providing
further evidence that testosterone itself may play a role in masculinization of the brain. I
should mention that these were the only references that demonstrated LH surges in males
compared to the large number of papers on induced anovulatory syndrome in females.
Therefore, the induction of LH surges in males appears to be more difficult, requiring
orchidectomy prenatally or early neonatally. This interpretation of the literature is consistent
with the theory suggested above, that feminization of LH regulation is a more intricate
process than feminization of many behaviors.
Evidence does exist on the differential roles of androgen and estrogen in sexual
differentiation of the brain. Studies have been conducted using 5a-dihydrotestosterone
(DHT), a non-aromatizable androgen. Valencia et al. (1992) have demonstrated that
postnatal administration of DHT to male pups reduced the volume of the rat accessory
olfactory bulb, a sexually dimorphic structure, to a volume not different from normal
females. Therefore, at least for this characteristic, DHT appeared to demasculinize the male
brain of rats. Tonjes and Domer (1987) have shown postnatal administration of DHT to
female pups increased sexually differentiated prepubertal play behavior to levels not different
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from normal juvenile males. Administration of EB to female pups, however, did not alter
prepubertal play behavior. Therefore, estrogen and androgens may be responsible for
different aspects of sex-specific brain differentiation.
The ability of cocaine to alter certain sexually differentiated behaviors and not certain
sexually differentiated physiological phenomena, in my case LH regulation, suggests a
theory of the process of sexual differentiation. Various sexually differentiated behaviors are
likely to be influenced by different areas of the brain. A particular female-typical behavior
may be controlled by certain areas of the brain, while a particular male-typical behavior may
be controlled by others. In the brain of a female, areas regulating female-typical behaviors
would develop, while the areas regulating male-typical behaviors would degenerate in some
sense, resulting in a genetic female with female-typical behaviors. The opposite would also
be true for males.
An important example of such a process of development can be found in other areas

of the body. Within the abdominal cavity of the undifferentiated fetus lie the Wolffian and
Muellerian ducts, which differentiate into the male and female internal genitalia. In the
presence of the testosterone, the Wolffian ducts develop into male internal genitalia and
secrete mullerian-inhibiting hormone (MIH), which causes regression of the Mullerian
ducts. In the absence of testosterone, the Wolffian ducts regress and MIH is not secreted.
Therefore, the Mullerian ducts develop (Diagram 3). In the internal genitalia model, it is
possible for both sets of organs to exist simultaneously. For example, in a genetic male with
normal testes, the Wolffian ducts will develop. If, however, the gene for MIH is nonfunctional, MIH would not be secreted, and therefore the Mullerian ducts would develop

Gonads
Miillerian duct

Wolffian duct

Diagram 3. Differentiation of the internal genitalia.
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82
along with the Wolffian ducts. In development of the internal genitalia, two separate
structures are present and in the presence of the appropriate signals either the female or the
male structures develop while the others regress. If this is also the case for development of
brain structures controlling sexually differentiated behaviors as I have suggested, then the
capacity to exhibit both male- and female-typical neural events in a single animal would be
possible.
The process of development is quite different, however, in the external genitalia. The
external genitalia of males and females develop from identical sexually indifferent
embryonic structures. In the presence of testosterone the urogenital fold, genital tubercle,
and labioscrotal swelling differentiate into the shaft of the penis, glans penis, and the
scrotum. In the absence of testosterone the undifferentiated external genitalia become the
labia minora, clitoral glans, and labia majora of females (Diagram 4). Unlike the internal
genitalia, the existence of both male and female external genitalia is not possible since both
differentiate from the same structures. There are cases where the external genitalia do not
fully develop into the male or female structures. These structures have an ambiguous
appearance that is somewhere between fully differentiated male and female structures. As
in the external genitalia model, some areas of the brain controlling LH regulation may
develop by a similar process. LH regulation may be controlled by one area of the brain that
is the same for both males and females. In the presence of testosterone, LH release displays
a tonic pattern typical of males. In the absence of testosterone, LH release displays a cyclic
pattern typical of females. The external genitalia model suggests that a certain structure is
basically neutral until a signal triggers which path of differentiation will be taken. If this is
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the case for the development of structures of the brain controlling LH regulation, the capacity
to generate both male and female patterns of LH release in a single individual is not possible.
Like the occasionally ambiguous structures of the external genitalia, however, a kind ofLH
regulation might exist somewhere on a spectrum between the extremes of a fully
differentiated male brain on one end and a fully differentiated female brain on the opposite
end.
These two models suggest a more complex model for development of sexually
differentiated behaviors and physiological processes, both contributing to a common
endpoint. I propose that separate sexually differentiated behaviors occur because separate
neural structures develop in the brains of males and females. Sexually differentiated LH
regulation, however, occurs because a single set of structures develops differently in males
and females. Since the basic model of development for sexually differentiated characteristics
may be different, different stimuli may have different effects on behavior and endocrinology.
This theory could explain the ability of cocaine to affect behavior but not LH regulation.
Vathy et al. (1993) have shown that prenatal exposure to cocaine (20mg/kgbwt) did reduce
female sexual behavior, but did not alter estrous cyclicity in female rats. Both cocainetreated and control females had similar 4-5 day estrous cycles. I also observed no alterations
in estrous cyclicity and further demonstrated that the capacity of females to respond to
steroidal positive-feedback stimulation was not different between control and cocaine-treated
rats, because the intensity of the LH surge was not different among treatment groups. Dohler

et al. (1991) have shown that neonatal treatment with L-tryptophan, a 5-HT precursor,
reduced the capacity for lordosis behavior but had no effect on LH regulation, demonstrating
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again the ability of a given stimulus to have different effects on various aspects of sexual
differentiation. Therefore, the developmental events that cause sex differences in behavior
and LH regulation may share some common elements, but may not be identical. In
summary, my experiment suggests that sexual differentiation of LH regulation may occur
by a different mechanism from sexual differentiation of behaviors. This model would
explain why some behaviors are affected by treatment with cocaine but LH regulation is not.
The purpose of my experiment was to study the effects of exposure to cocaine on
sexual differentiation of the brain. The increased use of cocaine by pregnant women
emphasizes the need to understand better the effects of cocaine on the developing fetus. I
have shown that cocaine does not appear to affect sexually differentiated LH regulation in
the developing rat. This result suggests that, although sexual differentiation of some
behaviors may be affected by prenatal exposure to cocaine, sex differences in basic
physiology are not compromised. I mentioned earlier that SDN-POA of the rat brain appears
to be influenced by endogenous steroid up until postnatal day 29, suggesting I may have not
exposed my pups long enough to cocaine's effects. In terms ofLH regulation, inducing LHsurges in males is only possible if the gonads are removed neonatally. Therefore, this
suggests that LH regulation is established during the time I exposed my pups to cocaine.
Understanding the complexities of sexual differentiation of the brain in humans or in rats is
far from complete and further research needs to be done. Sexual differentiation seems not
to be as simple as past models have suggested. Many questions remain unanswered,
including the exact roles of estrogen and testosterone, the interactions between NTs and
steroids, the possibility of different critical periods for different areas of the brain, and which
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specific areas of the brain control specific behaviors and physiological functions. Future
experiments regarding cocaine's effect on sexual differentiation may provide more insight
into sexual differentiation of the brain as a whole as well as possible options to protect
developing fetuses exposed to cocaine.
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